Earn continuing education credits by taking this quiz on the article that begins on page 30 of this issue. A grade of 70% or above will earn you a certificate of completion for two nationally certified continuing education hours. This is an open-book quiz. After reading the article, complete the quiz by circling one of the three multiple-choice answers for each question. Please give only one response per question. Incomplete answers will be marked as incorrect. Send a photocopy of the page along with your payment of $35 (NAADAC members) or $50 (nonmembers). Please complete fully the information section below; print clearly.
Data demonstrate buprenorphine's effectiveness
1. One of the two commonly used formulations of buprenorphine combines buprenorphine and:
2. The authors consider expansion of this a necessary factor in narrowing the opioid dependence treatment gap.
a. Office-based treatment
b. Public funding
c. Treatment that excludes pharmacology
3. The authors state that buprenorphine maintenance is not buprenorphine addiction because clients do not experience:
a. Physical dependence.
b. Withdrawal with abrupt cessation.
c. Compulsive, uncontrolled use.
4. The authors point to research showing this level of treatment retention with buprenorphine at the six-month mark.
a. 20 to 30%
b. 35 to 40%
c. 50 to 60%
5. A recent trial of buprenorphine detoxification approaches found this percentage of active use of illicit opioids among subjects after a taper.
6. The authors cite a study of long-term buprenorphine maintenance that found this percentage of opioid-positive drug tests during years 2 to 5 of follow-up.
7. The patients in the study that is referenced in quiz question 6 received this along with their medication.
a. Cognitive-behavioral therapy
b. Brief physician counseling
8. The authors consider buprenorphine to be:
a. A miracle cure for opioid dependence.
b. Sufficient without other interventions.
c. A vehicle for stabilization to allow the client to engage in rehabilitation.
9. The authors cite the problem of “script docs” who interact with patients during:
a. Phone appointments.
b. 5- to 10-minute refill visits.
c. Half-hour sessions.
10. The authors express concerns about “prescriptive detoxification” in office-based treatment that generally involves a taper of this duration.
a. 1 week
b. 4 weeks
c. 10 weeks
Addiction Professional 2011 January-February;9(1):37